336 related articles for article (PubMed ID: 30586697)
1. Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease.
Tsilingiri K; de la Fuente H; Relaño M; Sánchez-Díaz R; Rodríguez C; Crespo J; Sánchez-Cabo F; Dopazo A; Alonso-Lebrero JL; Vara A; Vázquez J; Casasnovas JM; Alfonso F; Ibáñez B; Fuster V; Martínez-González J; Martín P; Sánchez-Madrid F
Circulation; 2019 Jan; 139(2):243-255. PubMed ID: 30586697
[TBL] [Abstract][Full Text] [Related]
2. Resident Memory T Cells in the Atherosclerotic Lesion Associate With Reduced Macrophage Content and Increased Lesion Stability.
de Jong MJM; Depuydt MAC; Schaftenaar FH; Liu K; Maters D; Wezel A; Smeets HJ; Kuiper J; Bot I; van Gisbergen K; Slütter B
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1318-1329. PubMed ID: 38634281
[TBL] [Abstract][Full Text] [Related]
3. CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation.
Martín P; Gómez M; Lamana A; Cruz-Adalia A; Ramírez-Huesca M; Ursa MA; Yáñez-Mo M; Sánchez-Madrid F
Mol Cell Biol; 2010 Oct; 30(20):4877-89. PubMed ID: 20696842
[TBL] [Abstract][Full Text] [Related]
4. CD69: an unexpected regulator of TH17 cell-driven inflammatory responses.
Martín P; Sánchez-Madrid F
Sci Signal; 2011 Mar; 4(165):pe14. PubMed ID: 21427408
[TBL] [Abstract][Full Text] [Related]
5. Impaired Autophagy in CD11b
Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z
Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723
[TBL] [Abstract][Full Text] [Related]
6. Constitutive GITR Activation Reduces Atherosclerosis by Promoting Regulatory CD4+ T-Cell Responses-Brief Report.
Meiler S; Smeets E; Winkels H; Shami A; Pascutti MF; Nolte MA; Beckers L; Weber C; Gerdes N; Lutgens E
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1748-52. PubMed ID: 27444204
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling.
Saldanha-Araujo F; Haddad R; Farias KC; Souza Ade P; Palma PV; Araujo AG; Orellana MD; Voltarelli JC; Covas DT; Zago MA; Panepucci RA
J Cell Mol Med; 2012 Jun; 16(6):1232-44. PubMed ID: 21777379
[TBL] [Abstract][Full Text] [Related]
8. CD69-oxLDL ligand engagement induces Programmed Cell Death 1 (PD-1) expression in human CD4 + T lymphocytes.
Jiménez-Fernández M; Rodríguez-Sinovas C; Cañes L; Ballester-Servera C; Vara A; Requena S; de la Fuente H; Martínez-González J; Sánchez-Madrid F
Cell Mol Life Sci; 2022 Aug; 79(8):468. PubMed ID: 35930205
[TBL] [Abstract][Full Text] [Related]
9. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
[TBL] [Abstract][Full Text] [Related]
10. Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
Foks AC; Engelbertsen D; Kuperwaser F; Alberts-Grill N; Gonen A; Witztum JL; Lederer J; Jarolim P; DeKruyff RH; Freeman GJ; Lichtman AH
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):456-65. PubMed ID: 26821944
[TBL] [Abstract][Full Text] [Related]
11. Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content.
Brauner S; Jiang X; Thorlacius GE; Lundberg AM; Östberg T; Yan ZQ; Kuchroo VK; Hansson GK; Wahren-Herlenius M
Cardiovasc Res; 2018 Jan; 114(1):158-167. PubMed ID: 29016728
[TBL] [Abstract][Full Text] [Related]
12. CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation.
Ishikawa C; Kawakami H; Uchihara JN; Senba M; Mori N
Biochim Biophys Acta; 2013 Jun; 1833(6):1542-52. PubMed ID: 23507197
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
[TBL] [Abstract][Full Text] [Related]
14. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
[TBL] [Abstract][Full Text] [Related]
15. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice.
Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D
J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469
[TBL] [Abstract][Full Text] [Related]
16. CD69 Plays a Beneficial Role in Ischemic Stroke by Dampening Endothelial Activation.
Brait VH; Miró-Mur F; Pérez-de-Puig I; Notario L; Hurtado B; Pedragosa J; Gallizioli M; Jiménez-Altayó F; Arbaizar-Rovirosa M; Otxoa-de-Amezaga A; Monteagudo J; Ferrer-Ferrer M; de la Rosa X; Bonfill-Teixidor E; Salas-Perdomo A; Hernández-Vidal A; Garcia-de-Frutos P; Lauzurica P; Planas AM
Circ Res; 2019 Jan; 124(2):279-291. PubMed ID: 30582456
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD69 autoantibodies cross-react with low density lipoprotein receptor-related protein 2 in systemic autoimmune diseases.
Yu X; Matsui T; Otsuka M; Sekine T; Yamamoto K; Nishioka K; Kato T
J Immunol; 2001 Jan; 166(2):1360-9. PubMed ID: 11145721
[TBL] [Abstract][Full Text] [Related]
18. HMGB1Modulates the Treg/Th17 Ratio in Atherosclerotic Patients.
Ding JW; Zheng XX; Zhou T; Tong XH; Luo CY; Wang XA
J Atheroscler Thromb; 2016 Jun; 23(6):737-45. PubMed ID: 26830200
[TBL] [Abstract][Full Text] [Related]
19. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
Butcher MJ; Waseem TC; Galkina EV
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
[TBL] [Abstract][Full Text] [Related]
20. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
